Synergy between ethanol and grape polyphenols, quercetin, and resveratrol,in the inhibition of the inducible nitric oxide synthase pathway

Citation
Mmy. Chan et al., Synergy between ethanol and grape polyphenols, quercetin, and resveratrol,in the inhibition of the inducible nitric oxide synthase pathway, BIOCH PHARM, 60(10), 2000, pp. 1539-1548
Citations number
55
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BIOCHEMICAL PHARMACOLOGY
ISSN journal
00062952 → ACNP
Volume
60
Issue
10
Year of publication
2000
Pages
1539 - 1548
Database
ISI
SICI code
0006-2952(20001115)60:10<1539:SBEAGP>2.0.ZU;2-9
Abstract
In atherosclerosis and tumor initiation, inducible nitric oxide synthase (i NOS) has been implicated in the damage of Vascular walls and DNA, respectiv ely. Moderate consumption of red wine has been ascribed as a preventive for coronary heart disease; however, there has been much debate over whether t he beneficial effect is from grape polyphenolic components or ethanol. We s tudied the interaction of grape compounds on nitric oxide (NO) production b y macrophages, mediators of blood vessel damage in atherosclerosis. For the murine macrophage cell line RAW 264.7, stimulation with lipopolysaccharide and interferon-gamma led to expression of the iNOS gene and production of NO. The polyphenols quercetin and resveratrol at a micromolar range suppres sed iNOS gene expression and NO production, as determined by reverse transc ription-polymerase chain reaction and nitrite assay. The polyphenols were a lso found to be scavengers of NO in an acellular system using sodium nitrop russide under physiological conditions. Ethanol, at a moderate level, did n ot produce any appreciable level of reduction of iNOS or NO activity. Howev er, its presence at 0.1 to 0.75% enhanced the effect of grape polyphenols c oncentration-dependently. Thus, the interaction between these components pl ays a significant role in the health effects of red wine, especially with r espect to their effect on the NO pathway. (C) 2000 Elsevier Science Inc.